Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Gallenga

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Gene Therapy|November 19, 2017
The Role of Gene Therapy in the Treatment of Retinal Diseases: A ReviewC Campa, C E Gallenga, E Bolletta, et al.
Eye (London, England)|August 27, 2016
A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategiesF S Sorrentino, C E Gallenga, C Bonifazzi, et al.
Journal of Biological Regulators and Homeostatic Agents|June 15, 2019
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited?Al Caraffa, C E Gallenga, S K Kritas, et al.
Journal of Biological Regulators and Homeostatic Agents|June 9, 2021
Anaphylaxis is a rare reaction in COVID-19 vaccinationR G Bellomo, C E Gallenga, Al Caraffa, et al.
Journal of Biological Regulators and Homeostatic Agents|February 5, 2020
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategyS K Kritas, G Ronconi, Al Caraffa, et al.
Journal of Biological Regulators and Homeostatic Agents|January 11, 2020
CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37Al Caraffa, C E Gallenga, S K Kritas, et al.
Journal of Biological Regulators and Homeostatic Agents|June 2, 2020
SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokinesG Ronconi, G Teté, S K Kritas, et al.
Journal of Biological Regulators and Homeostatic Agents|February 2, 2021
How to classify the covid-19 phenotype: a response from <i>"the first soldier in the first trench"</i> in Lombardy, north-western ItalyC E Gallenga, C Contini, M Tana, et al.
Journal of Biological Regulators and Homeostatic Agents|April 27, 2021
Monoclonal antibody therapy in COVID-19P Conti, F E Pregliasco, V Calvisi, et al.
Journal of Biological Regulators and Homeostatic Agents|January 19, 2019
Interleukin-1 family cytokines and mast cells: activation and inhibitionC E Gallenga, F Pandolfi, Al Caraffa, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Gene Therapy|November 19, 2017
The Role of Gene Therapy in the Treatment of Retinal Diseases: A ReviewC Campa, C E Gallenga, E Bolletta, et al.
Eye (London, England)|August 27, 2016
A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategiesF S Sorrentino, C E Gallenga, C Bonifazzi, et al.
Journal of Biological Regulators and Homeostatic Agents|June 15, 2019
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited?Al Caraffa, C E Gallenga, S K Kritas, et al.
Journal of Biological Regulators and Homeostatic Agents|June 9, 2021
Anaphylaxis is a rare reaction in COVID-19 vaccinationR G Bellomo, C E Gallenga, Al Caraffa, et al.
Journal of Biological Regulators and Homeostatic Agents|February 5, 2020
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategyS K Kritas, G Ronconi, Al Caraffa, et al.
Journal of Biological Regulators and Homeostatic Agents|January 11, 2020
CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37Al Caraffa, C E Gallenga, S K Kritas, et al.
Journal of Biological Regulators and Homeostatic Agents|June 2, 2020
SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokinesG Ronconi, G Teté, S K Kritas, et al.
Journal of Biological Regulators and Homeostatic Agents|February 2, 2021
How to classify the covid-19 phenotype: a response from <i>"the first soldier in the first trench"</i> in Lombardy, north-western ItalyC E Gallenga, C Contini, M Tana, et al.
Journal of Biological Regulators and Homeostatic Agents|April 27, 2021
Monoclonal antibody therapy in COVID-19P Conti, F E Pregliasco, V Calvisi, et al.
Journal of Biological Regulators and Homeostatic Agents|January 19, 2019
Interleukin-1 family cytokines and mast cells: activation and inhibitionC E Gallenga, F Pandolfi, Al Caraffa, et al.
Pageof 3